June 11, 2013
Novartis Pharmaceuticals Corp. was slapped with a suit in New Jersey federal court Friday by a Sun Pharmaceutical Industries Ltd. unit demanding that it be free to market a generic version of blockbuster cancer drug Gleevec prior to the expiration of a Novartis patent.